Goldman Sachs’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $692M | Sell |
|
|||||
|
2025
Q1 | $760M | Sell |
|
|||||
|
2024
Q4 | $688M | Buy |
|
|||||
|
2024
Q3 | $599M | Sell |
|
|||||
|
2024
Q2 | $630M | Buy |
|
|||||
|
2024
Q1 | $380M | Sell |
|
|||||
|
2023
Q4 | $781M | Sell |
|
|||||
|
2023
Q3 | $832M | Buy |
|
|||||
|
2023
Q2 | $819M | Buy |
|
|||||
|
2023
Q1 | $870M | Buy |
|
|||||
|
2022
Q4 | $804M | Buy |
|
|||||
|
2022
Q3 | $491M | Sell |
|
|||||
|
2022
Q2 | $528M | Buy |
|
|||||
|
2022
Q1 | $434M | Buy |
|
|||||
|
2021
Q4 | $492M | Sell |
|
|||||
|
2021
Q3 | $529M | Sell |
|
|||||
|
2021
Q2 | $614M | Buy |
|
|||||
|
2021
Q1 | $212M | Buy |
|
|||||
|
2020
Q4 | $157M | Sell |
|
|||||
|
2020
Q3 | $208M | Sell |
|
|||||
|
2020
Q2 | $553M | Sell |
|
|||||
|
2020
Q1 | $623M | Sell |
|
|||||
|
2019
Q4 | $776M | Buy |
|
|||||
|
2019
Q3 | $623M | Sell |
|
|||||
|
2019
Q2 | $683M | Buy |
|
|||||
|
2019
Q1 | $631M | Buy |
|
|||||
|
2018
Q4 | $572M | Sell |
|
|||||
|
2018
Q3 | $753M | Buy |
|
|||||
|
2018
Q2 | $662M | Sell |
|
|||||
|
2018
Q1 | $964M | Buy |
|
|||||
|
2017
Q4 | $869M | Buy |
|
|||||
|
2017
Q3 | $913M | Buy |
|
|||||
|
2017
Q2 | $697M | Buy |
|
|||||
|
2017
Q1 | $615M | Buy |
|
|||||
|
2016
Q4 | $550M | Buy |
|
|||||
|
2016
Q3 | $432M | Sell |
|
|||||
|
2016
Q2 | $753M | Buy |
|
|||||
|
2016
Q1 | $623M | Sell |
|
|||||
|
2015
Q4 | $939M | Buy |
|
|||||
|
2015
Q3 | $865M | Sell |
|
|||||
|
2015
Q2 | $1.15B | Sell |
|
|||||
|
2015
Q1 | $1.92B | Sell |
|
|||||
|
2014
Q4 | $1.85B | Buy |
|
|||||
|
2014
Q3 | $1.75B | Sell |
|
|||||
|
2014
Q2 | $2.35B | Buy |
|
|||||
|
2014
Q1 | $1.44B | Buy |
|
|||||
|
2013
Q4 | $984M | Buy |
|
|||||
|
2013
Q3 | $651M | Buy |
|
|||||
|
2013
Q2 | $400M | Buy |
|